Dal Monte, Massimo
Evans, Bronwyn A.
Arioglu-Inan, Ebru
Michel, Martin C. http://orcid.org/0000-0003-4161-8467
Funding for this research was provided by:
TÜBITAK (SBAG-115S564)
Ankara Universitesi (15L0237005, 16L0237006, 17L0237002, 17L0230010)
Deutsche Forschungsgemeinschaft (Mi 294/10-1)
Article History
Received: 11 November 2019
Accepted: 22 November 2019
First Online: 18 December 2019
Compliance with ethical standards
:
: MCM is a consultant to Astellas and Velicept related to β<sub>3</sub>-adrenergic receptors and a shareholder of the latter company. MDM, BAE, and EAI do not report a conflict of interest.